Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Demeure

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
JCO Precision Oncology|June 22, 2022
Programmatic Efforts Increase Adoption of Genomic Precision Medicine in Cancer Care in a Community Cancer CenterSourat Darabi, David Braxton, Jeanne Homer, et al.
International Journal of Molecular Sciences|August 28, 2025
<i>BRAF</i> V600E Mutation Has Variable Tumor-Specific Effects on Expression of MAPK Pathway Genes That Could Affect Patient OutcomeSourat Darabi, Phillip Stafford, David R Braxton, et al.
World Journal of Surgery|March 18, 2014
Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic targetMichael J Demeure, Meraj Aziz, Richard Rosenberg, et al.
The Journal of Clinical Endocrinology and Metabolism|September 30, 2015
Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology GroupKeith C Bible, Gilbert J Cote, Michael J Demeure, et al.
World Journal of Surgery|May 23, 2002
Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidismJanice L Pasieka, Louise L Parsons, Michael J Demeure, et al.
F1000Research|November 13, 2023
Multiomic sequencing of paired primary and metastatic small bowel carcinoidsMackenzie D Postel, Sourat Darabi, James R Howe, et al.
Journal of Surgical Oncology|April 12, 2011
Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapyFrederick L Baehner, Mark Lee, Michael J Demeure, et al.
Current Problems in Surgery|October 24, 2006
Islet cell tumorsElizabeth A Mittendorf, Alexander L Shifrin, William B Inabnet, et al.
BMC Genomics|May 7, 2013
Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairsAlexis Christoforides, John D Carpten, Glen J Weiss, et al.
Clinical and Translational Medicine|January 13, 2016
Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinomaKimberly J Bussey, Aditi Bapat, Claire Linnehan, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
JCO Precision Oncology|June 22, 2022
Programmatic Efforts Increase Adoption of Genomic Precision Medicine in Cancer Care in a Community Cancer CenterSourat Darabi, David Braxton, Jeanne Homer, et al.
International Journal of Molecular Sciences|August 28, 2025
<i>BRAF</i> V600E Mutation Has Variable Tumor-Specific Effects on Expression of MAPK Pathway Genes That Could Affect Patient OutcomeSourat Darabi, Phillip Stafford, David R Braxton, et al.
World Journal of Surgery|March 18, 2014
Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic targetMichael J Demeure, Meraj Aziz, Richard Rosenberg, et al.
The Journal of Clinical Endocrinology and Metabolism|September 30, 2015
Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology GroupKeith C Bible, Gilbert J Cote, Michael J Demeure, et al.
World Journal of Surgery|May 23, 2002
Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidismJanice L Pasieka, Louise L Parsons, Michael J Demeure, et al.
F1000Research|November 13, 2023
Multiomic sequencing of paired primary and metastatic small bowel carcinoidsMackenzie D Postel, Sourat Darabi, James R Howe, et al.
Journal of Surgical Oncology|April 12, 2011
Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapyFrederick L Baehner, Mark Lee, Michael J Demeure, et al.
Current Problems in Surgery|October 24, 2006
Islet cell tumorsElizabeth A Mittendorf, Alexander L Shifrin, William B Inabnet, et al.
BMC Genomics|May 7, 2013
Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairsAlexis Christoforides, John D Carpten, Glen J Weiss, et al.
Clinical and Translational Medicine|January 13, 2016
Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinomaKimberly J Bussey, Aditi Bapat, Claire Linnehan, et al.
Pageof 8